» Articles » PMID: 20212918

Immunohistochemistry As an Important Tool in Biomarkers Detection and Clinical Practice

Overview
Publisher Sage Publications
Date 2010 Mar 10
PMID 20212918
Citations 154
Authors
Affiliations
Soon will be listed here.
Abstract

The immunohistochemistry technique is used in the search for cell or tissue antigens that range from amino acids and proteins to infectious agents and specific cellular populations. The technique comprises two phases: (1) slides preparation and stages involved for the reaction; (2) interpretation and quantification of the obtained expression. Immunohistochemistry is an important tool for scientific research and also a complementary technique for the elucidation of differential diagnoses which are not determinable by conventional analysis with hematoxylin and eosin. In the last couple of decades there has been an exponential increase in publications on immunohistochemistry and immunocytochemistry techniques. This review covers the immunohistochemistry technique; its history, applications, importance, limitations, difficulties, problems and some aspects related to results interpretation and quantification. Future developments on the immunohistochemistry technique and its expression quantification should not be disseminated in two languages-that of the pathologist and another of clinician or surgeon. The scientific, diagnostic and prognostic applications of this methodology must be explored in a bid to benefit of patient. In order to achieve this goal a collaboration and pooling of knowledge from both of these valuable medical areas is vital.

Citing Articles

CMTM4 promotes the motility of colon cancer cells under radiation and is associated with an unfavorable neoadjuvant chemoradiotherapy response and patient survival in rectal cancer.

Yang L, Miao Z, Li N, Meng L, Feng Q, Qiao D Oncol Lett. 2025; 29(3):138.

PMID: 39839608 PMC: 11747855. DOI: 10.3892/ol.2025.14884.


Gold Nanoprism Enhanced SERS Aptasensor for Simultaneous Detection of Thrombin and VEGF.

Anantha P, Raj P, Zheng P, Tanwar S, Barman I Sens Actuators B Chem. 2025; 423.

PMID: 39744119 PMC: 11687365. DOI: 10.1016/j.snb.2024.136811.


Spectrum of Ductal Carcinoma In Situ (DCIS) Lesions of the Breast: From Morphology to Molecular Characteristics.

Sathvik G, V P, Joseph L, Challa C Cureus. 2024; 16(9):e69929.

PMID: 39439618 PMC: 11495678. DOI: 10.7759/cureus.69929.


Antibody-Drug Conjugates and Their Potential in the Treatment of Patients with Biliary Tract Cancer.

Alexander S, Aleem U, Jacobs T, Frizziero M, Foy V, Hubner R Cancers (Basel). 2024; 16(19).

PMID: 39409965 PMC: 11476249. DOI: 10.3390/cancers16193345.


Accelerating histopathology workflows with generative AI-based virtually multiplexed tumour profiling.

Pati P, Karkampouna S, Bonollo F, Comperat E, Radic M, Spahn M Nat Mach Intell. 2024; 6(9):1077-1093.

PMID: 39309216 PMC: 11415301. DOI: 10.1038/s42256-024-00889-5.


References
1.
Smejkal G, SHAINOFF J . Enhanced digital imaging of diaminobenzidene-stained immunoblots. Biotechniques. 1997; 22(3):462. DOI: 10.2144/97223bm20. View

2.
Hsi E . A practical approach for evaluating new antibodies in the clinical immunohistochemistry laboratory. Arch Pathol Lab Med. 2001; 125(2):289-94. DOI: 10.5858/2001-125-0289-APAFEN. View

3.
Ruifrok A . Quantification of immunohistochemical staining by color translation and automated thresholding. Anal Quant Cytol Histol. 1997; 19(2):107-13. View

4.
Field J, Spandidos D, Yiagnisis M, Gosney J, Papadimitriou K, Stell P . C-erbB-2 expression in squamous cell carcinoma of the head and neck. Anticancer Res. 1992; 12(3):613-9. View

5.
Lehr H, Jacobs T, Yaziji H, Schnitt S, Gown A . Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. Am J Clin Pathol. 2001; 115(6):814-22. DOI: 10.1309/AJ84-50AK-1X1B-1Q4C. View